Cargando…

Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)FDG-PET studies in schizophrenia

BACKGROUND: Impaired brain metabolism may be central to schizophrenia pathophysiology, but the magnitude and consistency of metabolic dysfunction is unknown. METHODS: We searched MEDLINE, PsychINFO and EMBASE between 01/01/1980 and 13/05/2021 for studies comparing regional brain glucose metabolism u...

Descripción completa

Detalles Bibliográficos
Autores principales: Townsend, Leigh, Pillinger, Toby, Selvaggi, Pierluigi, Veronese, Mattia, Turkheimer, Federico, Howes, Oliver
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476075/
https://www.ncbi.nlm.nih.gov/pubmed/35730361
http://dx.doi.org/10.1017/S003329172200174X
_version_ 1785100847985721344
author Townsend, Leigh
Pillinger, Toby
Selvaggi, Pierluigi
Veronese, Mattia
Turkheimer, Federico
Howes, Oliver
author_facet Townsend, Leigh
Pillinger, Toby
Selvaggi, Pierluigi
Veronese, Mattia
Turkheimer, Federico
Howes, Oliver
author_sort Townsend, Leigh
collection PubMed
description BACKGROUND: Impaired brain metabolism may be central to schizophrenia pathophysiology, but the magnitude and consistency of metabolic dysfunction is unknown. METHODS: We searched MEDLINE, PsychINFO and EMBASE between 01/01/1980 and 13/05/2021 for studies comparing regional brain glucose metabolism using (18)FDG-PET, in schizophrenia/first-episode psychosis v. controls. Effect sizes (Hedges g) were pooled using a random-effects model. Primary measures were regional absolute and relative CMRGlu in frontal, temporal, parietal and occipital lobes, basal ganglia and thalamus. RESULTS: Thirty-six studies (1335 subjects) were included. Frontal absolute glucose metabolism (Hedge's g = −0.74 ± 0.54, p = 0.01; I(2) = 67%) and metabolism relative to whole brain (g = −0.44 ± 0.34, p = 0.01; I(2) = 55%) were lower in schizophrenia v. controls with moderate heterogeneity. Absolute frontal metabolism was lower in chronic (g = −1.18 ± 0.73) v. first-episode patients (g = −0.09 ± 0.88) and controls. Medicated patients showed frontal hypometabolism relative to controls (−1.04 ± 0.26) while metabolism in drug-free patients did not differ significantly from controls. There were no differences in parietal, temporal or occipital lobe or thalamic metabolism in schizophrenia v. controls. Excluding outliers, absolute basal ganglia metabolism was lower in schizophrenia v. controls (−0.25 ± 0.24, p = 0.049; I(2) = 5%). Studies identified reporting voxel-based morphometry measures of absolute (18)FDG uptake (eight studies) were also analysed using signed differential mapping analysis, finding lower (18)FDG uptake in the left anterior cingulate gyrus (Z = −4.143; p = 0.007) and the left inferior orbital frontal gyrus (Z = −4.239; p = 0.02) in schizophrenia. CONCLUSIONS: We report evidence for hypometabolism with large effect sizes in the frontal cortex in schizophrenia without consistent evidence for alterations in other brain regions. Our findings support the hypothesis of hypofrontality in schizophrenia.
format Online
Article
Text
id pubmed-10476075
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-104760752023-09-05 Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)FDG-PET studies in schizophrenia Townsend, Leigh Pillinger, Toby Selvaggi, Pierluigi Veronese, Mattia Turkheimer, Federico Howes, Oliver Psychol Med Original Article BACKGROUND: Impaired brain metabolism may be central to schizophrenia pathophysiology, but the magnitude and consistency of metabolic dysfunction is unknown. METHODS: We searched MEDLINE, PsychINFO and EMBASE between 01/01/1980 and 13/05/2021 for studies comparing regional brain glucose metabolism using (18)FDG-PET, in schizophrenia/first-episode psychosis v. controls. Effect sizes (Hedges g) were pooled using a random-effects model. Primary measures were regional absolute and relative CMRGlu in frontal, temporal, parietal and occipital lobes, basal ganglia and thalamus. RESULTS: Thirty-six studies (1335 subjects) were included. Frontal absolute glucose metabolism (Hedge's g = −0.74 ± 0.54, p = 0.01; I(2) = 67%) and metabolism relative to whole brain (g = −0.44 ± 0.34, p = 0.01; I(2) = 55%) were lower in schizophrenia v. controls with moderate heterogeneity. Absolute frontal metabolism was lower in chronic (g = −1.18 ± 0.73) v. first-episode patients (g = −0.09 ± 0.88) and controls. Medicated patients showed frontal hypometabolism relative to controls (−1.04 ± 0.26) while metabolism in drug-free patients did not differ significantly from controls. There were no differences in parietal, temporal or occipital lobe or thalamic metabolism in schizophrenia v. controls. Excluding outliers, absolute basal ganglia metabolism was lower in schizophrenia v. controls (−0.25 ± 0.24, p = 0.049; I(2) = 5%). Studies identified reporting voxel-based morphometry measures of absolute (18)FDG uptake (eight studies) were also analysed using signed differential mapping analysis, finding lower (18)FDG uptake in the left anterior cingulate gyrus (Z = −4.143; p = 0.007) and the left inferior orbital frontal gyrus (Z = −4.239; p = 0.02) in schizophrenia. CONCLUSIONS: We report evidence for hypometabolism with large effect sizes in the frontal cortex in schizophrenia without consistent evidence for alterations in other brain regions. Our findings support the hypothesis of hypofrontality in schizophrenia. Cambridge University Press 2023-08 2022-06-22 /pmc/articles/PMC10476075/ /pubmed/35730361 http://dx.doi.org/10.1017/S003329172200174X Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Townsend, Leigh
Pillinger, Toby
Selvaggi, Pierluigi
Veronese, Mattia
Turkheimer, Federico
Howes, Oliver
Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)FDG-PET studies in schizophrenia
title Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)FDG-PET studies in schizophrenia
title_full Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)FDG-PET studies in schizophrenia
title_fullStr Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)FDG-PET studies in schizophrenia
title_full_unstemmed Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)FDG-PET studies in schizophrenia
title_short Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)FDG-PET studies in schizophrenia
title_sort brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of (18)fdg-pet studies in schizophrenia
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476075/
https://www.ncbi.nlm.nih.gov/pubmed/35730361
http://dx.doi.org/10.1017/S003329172200174X
work_keys_str_mv AT townsendleigh brainglucosemetabolisminschizophreniaasystematicreviewandmetaanalysisof18fdgpetstudiesinschizophrenia
AT pillingertoby brainglucosemetabolisminschizophreniaasystematicreviewandmetaanalysisof18fdgpetstudiesinschizophrenia
AT selvaggipierluigi brainglucosemetabolisminschizophreniaasystematicreviewandmetaanalysisof18fdgpetstudiesinschizophrenia
AT veronesemattia brainglucosemetabolisminschizophreniaasystematicreviewandmetaanalysisof18fdgpetstudiesinschizophrenia
AT turkheimerfederico brainglucosemetabolisminschizophreniaasystematicreviewandmetaanalysisof18fdgpetstudiesinschizophrenia
AT howesoliver brainglucosemetabolisminschizophreniaasystematicreviewandmetaanalysisof18fdgpetstudiesinschizophrenia